During the past decade, Med-Care Research conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 3 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Med-Care Research" #1 sponsor was "Biohaven Pharmaceuticals, Inc." with 2 trials, followed by "Sorrento Therapeutics, Inc." with 2 trials sponsored, "American Regent, Inc." with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Esperion Therapeutics, Inc." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Med-Care Research" #1 collaborator was "DSM Nutritional Products, Inc." with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "SerenaGroup, Inc." with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Med-Care Research" are "Covid19" (2 trials), "Alzheimer Disease" (1 trials), "Cardiovascular Diseases" (1 trials), "Diabetes" (1 trials) and "Diabetic Foot Ulcer" (1 trials). Many other conditions were trialed in "Med-Care Research" in a lesser frequency.

Most popular intervention types in "Med-Care Research" are "Drug" (8 trials), "Biological" (2 trials), "Device" (2 trials), "Behavioral" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Bempedoic acid 180 mg tablet" (1 trials), "Blood Biomarkers" (1 trials), "Blood glucose meter" (1 trials) and "COVI-AMG" (1 trials). Other intervention names were less common.

The vast majority of trials in "Med-Care Research" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Med-Care Research". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 6 completed trials in Med-Care Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Med-Care Research, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".